Bedel Financial Consulting’s Vaxart VXRT Stock Holding History

Bedel Financial Consulting’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15	Closed	–	–	907
2022 Q1	$0	Hold	15	–	–	﹤0.01%	1074
2021 Q4	$0	Hold	15	–	–	﹤0.01%	1085
2021 Q3	$0	Hold	15	–	–	﹤0.01%	1034
2021 Q2	$0	Hold	15	–	–	﹤0.01%	1015
2021 Q1	$0	Buy	+15	New	+$115	﹤0.01%	974

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bedel Financial Consulting's VXRT Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Vaxart (VXRT) in Q2 2022, closing a stake of 15 shares.

Bedel Financial Consulting first reported a position in VXRT in Q1 2021 and held it in 5 quarters. The position peaked at $0 in Q1 2022. 146 funds tracked by Wall St. Rank hold VXRT as of Q2 2022.

Bedel Financial Consulting reported no remaining Vaxart position as of Q2 2022 after selling out during the quarter.
Bedel Financial Consulting sold 15 Vaxart shares in Q2 2022.
Bedel Financial Consulting first reported a position in Vaxart in Q1 2021 and held it in 5 quarters.
Bedel Financial Consulting's Vaxart position peaked at $0 in Q1 2022.
146 funds tracked by Wall St. Rank held Vaxart as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.